Network·Hedge Fund
📍 PARIS
SEC CRD #802-75246
Astorg - Astorg | Uncovering value through the art of listening Skip to content Uncovering value through the art of listening Astorg approaches private equity differently. The art of listening is at the heart of our culture. By establishing a true, respectful dialogue, we uncover the vision, ambition and beliefs of the businesses we invest in – where true value lies. We can then reach the genuine alignment of management and shareholders that leads to the seamless execution of value-creating strategies. We listen. We challenge. We align. More about us Astorg in numbers Generation buyout fund 8th Annualized return 27% Assets under management €24bn Latest news Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform Healthcare 04 June 2026 Astorg-backed Steliau to acquire Acal BFI, strengthening its position as the leading European platform in value-added electronic solutions Business Services 01 June 2026 Astorg to Acquire Global Microbiology Business from Thermo Fisher Scientific Healthcare 27 April 2026 More news Our investments We work with entrepreneurs and management teams we trust, providing them with the strategic guidance, governance and capital they need to achieve their growth goals. Find out more IPL IPL is a leading UK-based provider of infection prevention devices for patients on long-term vascular access treatment. Investment year: 2026 Healthcare In Portfolio Solabia Solabia is a
STIJN CURFS
HEAD OF CORPORATE LEGAL
📞 33 153054050
🔒 Sign up for free to view key contact information
Sign up free →This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Check Size
$2.0B–$2.0B
Location
PARIS
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.